Beijing: China has reportedly approved patent for CanSino Biologics Inc’s COVID-19 vaccine — Ad5-nCOV. It is the first patent granted by China for a COVID-19 vaccine.
Saudi Arabia will be carrying out the Phase-III clinical trials for the CanSino vaccine this month.
CanSino is exploring testing the vaccine in Russia, Brazil and Chile as well. CanSino’s Hong Kong shares rose by around 14 per cent on Monday.
Also Read: First Batch Of Russian COVID-19 Vaccine To Roll Out This Month
Mumbai: ‘Emergency’ actor-director Kangana Ranaut has finally opened up about her film not being allowed…
Bhubaneswar: Odisha's main opposition party Biju Janata Dal (BJD) has appointed its MLA Pratap Keshari…
Washington: The differences in opinion, the bitter mutual attacks during the Presidential campaign were forgotten on…
Sundargarh: Some unidentified miscreants allegedly looted ornaments and cash worth over Rs 1.5 crore from…
Mumbai: Several websites and social media handles recently carried reports about Tabu's views on marriage,…
Bhubaneswar: Tata Power Renewable Energy Limited (TPREL) has signed a Memorandum of Understanding (MoU) with…
This website uses cookies.
